CHROME 200 µg
Food supplement declared in France, declaration No 2019-6-785
CHROME 200 µg (ORFITO) is a food supplement declared in France. Status: retiré du marché le 25 September 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked. Its name nevertheless states a dose above the maximum set in France in 2006: see the composition.
- Brand
- ORFITO
- Food business operator placing the product on the market
- BioUltime
- Status
- Retiré du marché le 25 September 2026
- Form
- Comprimé
- Daily dose
- 1 comprimé
- Directions for use
- 1 comprimé par jour. A avaler avec un verre d’eau au cours du repas.
Declaration 164414, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 25 September 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Son de riz | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Picolinate de chrome | Chrome | pas de limite (données insuffisantes) | 25 µg |
The product name states 200 µg of chrome per serving, above the maximum dose of 25 µg set by the Order of 9 May 2006, not revised since November 2006. Check the dose and number of servings on the label.
Additives
E460, E341, E470b
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Femmes enceintes ou allaitantes consulter un professionnel de santé avant utilisation.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : ORFITO